Literature DB >> 1082390

Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.

W J Catalona, J L Tarpley, C Potvin, P B Chretien.   

Abstract

Comparisons of the results obtained in a study of fifty-two patients with genitourinary malignancies using three assays to monitor the thymus-dependent immune system (delayed cutaneous hypersensitivity to DNCB, PHA-induced lymphocyte blastogenesis, and peripheral blood E rosette-forming lymphocyte counts) yielded statistically significant positive correlations between the DNCB and PHA assays in twenty-one of twenty-eight instances, the DNCB and E rosette assays in thirteen of sixteen instances, the PHA and E rosette assays in twenty-eight of thirty-six instances, and among the DNCB, PHA and E rosette assays in ten of fourteen instances. The results suggest that both PHA-stimulated lymphocyte blastogenesis and peripheral blood E rosette-forming lymphocyte levels provide meaningful in vitro correlates of cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1082390      PMCID: PMC1538092     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Evidence for transformation of human B lymphocytes by PHA.

Authors:  B Phillips; I M Roitt
Journal:  Nat New Biol       Date:  1973-02-21

2.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

3.  Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.

Authors:  A Brugarolas; T Han; H Takita; J Minowada
Journal:  N Y State J Med       Date:  1973-03-15

4.  Lymphocyte stimulation tests in cancer patients.

Authors:  T X O'Connell; S H Golub; D L Morton
Journal:  Surg Forum       Date:  1973

5.  Lymphocyte response to phytohemagglutinin in Hodgkin's disease.

Authors:  T Han; J E Sokal
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

6.  Rosette formation by peripheral lymphocytes.

Authors:  P Brain; J Gordon; W A Willetts
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

7.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

8.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  4 in total

1.  The incorrect use of Chi-square analysis for paired data.

Authors:  J I Hoffman
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

2.  [Skin tests with phytohaemagglutinin (PHA). Correlation with other parameters of cell-mediated immunity (author's transl)].

Authors:  U Breuer; D Strassburger; G Goerz; A Greither
Journal:  Arch Dermatol Res       Date:  1976-11-26       Impact factor: 3.017

3.  Immunological state of patients with carcinoma of the bronchus before and after radiotherapy.

Authors:  A M Savage; J A Pritchard; T J Deeley; B H Davies
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

4.  Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.

Authors:  R A Fromtling; R Blackstock; N K Hall; G S Bulmer
Journal:  Mycopathologia       Date:  1979-09-28       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.